Among them, the up-regulated DEGs were mostly enriched in ‘metabolic pathways’ and ‘pathways in cancer’, and the down-regulated DEGs were mainly enriched in ‘PI3K–Akt signaling pathway’, ‘metabolic pathway’, and ‘pathways in cancer’ (Figure 1B). The gene discussed is AKT1; the disease is cancer.